Table 1
Open in new tab

Patient’s characteristics in both groups   

AbandonmentExtractionP (univariate analysis)P (multivariate analysis)
Male78.1%79%NSNS
Age65 ± 12.756.7 ± 14.5<0.0001<0.0001
BMI27 ± 4.926.6 ± 5.4NSNS
Ischaemic cardiopathy49.6%40.5%0.03NS
Presence of comorbiditiesa58.3%46.5%0.0060.022
Anticoagulants36.3%28.4%NSNS
AbandonmentExtractionP (univariate analysis)P (multivariate analysis)
Male78.1%79%NSNS
Age65 ± 12.756.7 ± 14.5<0.0001<0.0001
BMI27 ± 4.926.6 ± 5.4NSNS
Ischaemic cardiopathy49.6%40.5%0.03NS
Presence of comorbiditiesa58.3%46.5%0.0060.022
Anticoagulants36.3%28.4%NSNS
a

Hypertension, diabetes, renal failure, or atrial fibrillation.

Table 1
Open in new tab

Patient’s characteristics in both groups   

AbandonmentExtractionP (univariate analysis)P (multivariate analysis)
Male78.1%79%NSNS
Age65 ± 12.756.7 ± 14.5<0.0001<0.0001
BMI27 ± 4.926.6 ± 5.4NSNS
Ischaemic cardiopathy49.6%40.5%0.03NS
Presence of comorbiditiesa58.3%46.5%0.0060.022
Anticoagulants36.3%28.4%NSNS
AbandonmentExtractionP (univariate analysis)P (multivariate analysis)
Male78.1%79%NSNS
Age65 ± 12.756.7 ± 14.5<0.0001<0.0001
BMI27 ± 4.926.6 ± 5.4NSNS
Ischaemic cardiopathy49.6%40.5%0.03NS
Presence of comorbiditiesa58.3%46.5%0.0060.022
Anticoagulants36.3%28.4%NSNS
a

Hypertension, diabetes, renal failure, or atrial fibrillation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close